Men with Type 2 diabetes who were prescribed Viagra-type drugs for improving erections were 31% less likely to die than men of the same age who were not prescribed these drugs during an average follow-up of 7.5 years according to a recent study.

The risk of dying was 46% less after adjusting for age, kidney function, smoking status, prior stroke, hypertension, prior myocardial infarction, systolic blood pressure, use of statin, metformin, aspirin and β-blocker medication,

The study looked at the use of phosphodiesterase type-5 inhibitors which include sildenafil (Viagra), tadalafil (Cialis), vardenafil (Levitra) and avanafil (Stendra).

Men with Type 2 diabetes who were prescribed Viagra-type drugs for improving erections were 38% less likely to have a heart attack compared to men who were not prescribed these drugs during an average follow-up of 7.5 years according to a recent study.

The study looked at the use of phosphodiesterase type-5 inhibitors which include sildenafil (Viagra), tadalafil (Cialis), vardenafil (Levitra) and avanafil (Stendra).